HAE
HAE
NYSE · Health Care

Haemonetics Corp/Mass

$55.93
-0.73 (-1.29%)
As of Mar 25, 8:55 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 5 33%
Sell 0 0%
Price Target
Analyst Price Target +21.2% upside
Low Target $49.76
Average Target $67.77
High Target $94.95
Current Price $55.93
Current
$55.93
Target
$67.77
$49.76 $67.77 avg $94.95
Scenario Analysis
Bear Case
$49.76
-11.0%
Low target
Base Case
$67.77
+21.2%
Avg target
Bull Case
$94.95
+69.8%
High target
Risk/Reward
6.3x
Highly favorable
Price in Context
52-Week High
$87.32
-35.9% from high
52-Week Low
$47.32
+18.2% from low
50-Day SMA
$73.38
-23.8% vs SMA
200-Day SMA
$66.27
-15.6% vs SMA
RSI (14)
35.9
Neutral
Target vs 52W High
$67.77
-22.4% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +8.6%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +17.8%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -53.2%
SYK
Stryker Corp
Strong Buy 37 76% $338.36 +3.3%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -75.5%
MDT
Medtronic Plc
Buy 38 63% $192.46 +119.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -65.1%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +95.4%